CDA-AMC

UCB Receives Favorable Canadian Reimbursement Opinion for BIMZELX

OAKVILLE, Ontario, June 9, 2026 UCB Canada announced that BIMZELX® (bimekizumab injection) received a positive reimbursement recommendation with conditions...

By cGxPwire Editor
June 11, 2026

.Clinical

Roche’s Gazyva Moves Closer to Public Access in Canada for Lupus Nephritis

MISSISSAUGA, Ontario, May 22, 2026 Roche Canada announced that Canada’s Drug Agency (CDA-AMC) has issued a positive reimbursement recommendation...

By cGxPwire Editor
May 25, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

CDA-AMC

UCB Receives Favorable Canadian Reimbursement Opinion for BIMZELX

Roche’s Gazyva Moves Closer to Public Access in Canada for Lupus Nephritis